PI3K Inhibitors
Copanlisib (trade name Aliqopa), is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies...Wikipedia
Manufacturer's Website: Aliqopa
Average retail cost: $4,300/vial
Copyright 2006-2023 Automated Clinical Guidelines, LLC. All rights reserved.
Home Contact FAQ
Account